# Key Papers and References

## Agentic AI Systems in Drug Discovery

### Recent Demonstrations (2023-2026)
- **He et al. 2026** - ChatInvent: 13-month deployment at AstraZeneca for literature synthesis and hypothesis generation (*Drug Discovery Today*)
- **Boiko et al. 2023** - Coscientist: Autonomous chemical synthesis planning and execution (*Nature*)
- **Bran et al. 2023** - ChemCrow: GPT-4 orchestrating 18 chemistry tools for synthesis planning (*Nature Machine Intelligence*)
- **Swanson et al. 2024** - PharmAgents: LLM + knowledge graph queries for drug discovery (*arXiv*)

### Surveys and Perspectives
- **Seal et al. 2025** - Comprehensive survey of AI agents in drug discovery, notes LLM-centric design patterns (*arXiv*)
- **Lakhan 2025** - "The Agentic Era" editorial, assumes large pharma budgets (*Cureus*)

## Protein Language Models and Peptide Design

- **Ferruz et al. 2022** - ProtGPT2: Generative protein language model
- **Lin et al. 2023** - ESM-2: Evolutionary scale modeling for protein sequences
- **Rives et al. 2021** - ESM-2 foundations: Learning protein language at scale
- **Elnaggar et al. 2021** - ProtBERT: Protein language models for sequence understanding
- **Madani et al. 2023** - ProGen2: Large-scale protein generation
- **Jumper et al. 2021** - AlphaFold2: Protein structure prediction breakthrough
- **AlQuraishi 2019** - Review of protein structure prediction paradigms

## In Vivo Modeling and Multi-Objective Optimization

- **Stokes et al. 2020** - Machine learning for antibiotic discovery using multi-paradigm approaches (*Cell*)
- **Mathis et al. 2018** - DeepLabCut: Markerless pose estimation for animal behavior analysis
- **Reker 2020** - Multi-objective optimization strategies in drug discovery
- **Grisoni et al. 2021** - Balancing activity, selectivity, and drug-likeness in molecular design

## Computational Drug Discovery Methods

- **Schneider et al. 2020** - Review of generative models for drug discovery
- **Zhou et al. 2023** - Reinforcement learning approaches for molecular design
- **Bickerton et al. 2012** - Quantitative estimate of drug-likeness (QED)

## Biological Databases and Pathway Analysis

- **Kanehisa et al. 2023** - KEGG: Kyoto Encyclopedia of Genes and Genomes for pathway analysis
- **Subramanian et al. 2005** - GSEA: Gene Set Enrichment Analysis methodology

## Drug Development Economics

- **DiMasi et al. 2016** - Drug development costs: Small biotech vs. pharmaceutical company economics

## Industry Tools and Platforms

- **TxGemma (Google, 2024)** - Therapeutic target prediction model

---

## Papers to Add (from outline review)

Additional references mentioned in outline but needing full citations:
- MADD system (mentioned in timeline)
- DiscoVerse system (mentioned in timeline)
- Aoun & Garg 2025 (mentioned in README as related survey)

---

## Citation Style Note

Full bibliographic entries to be added during manuscript drafting phase. Current format follows author-year convention common in computational biology venues.

**Last updated**: 2026-02-05
